Topics
News
CME/CE
Editorial Advisory Board
Partners
Subscribe
- Case-Based Roundtable
- General Dermatology
- Eczema
- Chronic Hand Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Prurigo Nodularis
- Buy-and-Bill
Opinion
Video
Advancing to Systemic Treatment in an 8-Year-Old Girl With Atopic Dermatitis
Author(s):
The panelist discusses how an 8-year-old girl with moderate to severe atopic dermatitis requires a comprehensive treatment approach focusing on dupilumab as a potential systemic therapy. Treatment goals include reducing inflammation, improving quality of life, and providing age-appropriate, empathetic care while addressing patient and caregiver concerns about efficacy and safety.
Video content above is provided by the following:
- Please share your impressions of the case. What aspects of the case are most relevant for treatment consideration?
- What are your treatment goals for this patient?
- Describe your approach to pharmacologic treatment for this patient. Would her history and presentation make her a candidate for systemic therapy?
- How do you approach the conversation with pediatric patients and their caregivers when initiating a systemic, injectable treatment for atopic dermatitis?
- What should this patient expect in terms of efficacy and safety with dupilumab? How soon can she expect initial symptom relief?
- How would you address potential patient/caregiver concerns such as fear of injections or adverse effects and long-term safety with dupilumab?
Related Videos
Related Content
